Microlife Device Validation Table
Download Microlife Publication as PDF here.
Download as PDF here.
Upper arm Automatic | |||||
Device | AAMI | BHS | ESH | Circumstance | Reference |
Microlife BP 3AS1-2 | Pass | At rest | 1 | ||
Microlife WatchBP O3 (3MZ0) | Pass | At rest | 2 | ||
Microlife WatchBP O3 (3MZ1) | Pass | At rest | 3 | ||
Microlife WatchBP Office | Pass | At rest | 4 | ||
Microlife WatchBP Office ABI | A/A | Pass | At rest | 5 | |
Pass | L-XL size cuff | 4,6 | |||
Accuracy in assessing ABI | 7 | ||||
Accuracy in detecting Atrial Fibrillation | 8,9 | ||||
Microlife WatchBP Office AFIB | Pass | WatchBP Office Equivalence | 4* | ||
Accuracy in detecting Atrial Fibrillation | 8, 9 | ||||
Microlife WatchBP Office Target | Pass | BP A100 Equivalence | 10* | ||
Self-measurement devices | |||||
Device | AAMI | BHS | ESH | Circumstance | Reference |
Microlife BP 3AC1-1 | Pass | At rest | 11 | ||
Pass | A/A | Pregnancy; Abstract | 12 | ||
Pass | B/A | Pre-eclampsia; Abstract | 12 | ||
Microlife BP 3AC1-1 PC | Pass | BP 3AC1-1 Equivalence | 11* | ||
Pass | ESRD population | 13 | |||
Microlife BP 3AC1-2 | Pass | BP 3AC1-1 Equivalence | 11* | ||
Microlife BP 3AG1 | A/A | BP 3BT0-A Equivalence | 14* | ||
Microlife BP 3BTO-1 | A/A | BP 3BT0-A Equivalence | 14* | ||
Microlife BP 3BTO-A | A/A | Small recruitment violation | 14 | ||
Pass | A/B | Normotensive Pregnancy | 15 | ||
Pass | B/B | Non-proteinuric HBP | 15 | ||
Pass | A/B | Pre-Eclampsia | 15 | ||
Microlife BP 3BTO-A(2) | A/A | BP 3BT0-A Equivalence | 15* | ||
Microlife BP 3BTO-AP | A/A | BP 3BT0-A Equivalence | 14* | ||
Microlife BP A1 Easy (BP3GR1-1P) | A/A | Pass | BP A100 Plus and BP 3BT0-A Equivalences | 16 | |
Pass | A/B | Normotensive Pregnancy | 10 | ||
Pass | B/B | Non-proteinuric HBP | 10 | ||
Pass | A/B | Pre-Eclampsia | 17 | ||
Microlife BP A2 Basic (BP3GQ1-3P) | A/A | Pass | BP A100 Plus and BP 3BT0-A Equivalences | 16 | |
Pass | A/B | Normotensive Pregnancy | 10 | ||
Pass | B/B | Non-proteinuric HBP | 10 | ||
Pass | A/B | Pre-Eclampsia | 17 | ||
Microlife BP A6 PC (BP3GU1-8Y) | A/A | Pass | BP A100 Plus and BP 3BT0-A Equivalences | 16 | |
Pass | A/B | Normotensive Pregnancy | 10 | ||
Pass | B/B | Non-proteinuric HBP | 10 | ||
Pass | A/B | Pre-Eclampsia | 17 | ||
Microlife BP A100 | Pass | BP A100 Plus Equivalence | 16 | ||
Pass | With M-L Soft Cuff | 10 | |||
Pass | With M-L Rigid Conical Cuff | 17 | |||
Microlife BP A100 Plus | Pass | At rest | 10 | ||
Pass | At rest | 17 | |||
Microlife Exact BP (BP3MD1-3) | Pass | BP A100 Equivalence | 16 | ||
Microlife RM 100 | A/A | BP 3BT0-A Equivalence | 14* | ||
Microlife WatchBP Home (BP3MX1-1) | Pass | At rest | 18 | ||
Pass | A/A | Pregnancy | 19 | ||
Pass | A/A | Pre-eclampsia | 19 | ||
Microlife WatchBP Home A (BP3MX1-3) | Pass | Watch BP Home Equivalence | 18,19* | ||
Accuracy in detecting Atrial Fibrillation | 8,9 | ||||
Microlife WatchBP Home N (BP3MX1-4) | Pass | Watch BP Home Equivalence | 18,19* | ||
Microlife WatchBP Home S (BP3MX1-5) | Pass | Watch BP Home Equivalence | 18,19* | ||
Accuracy in detecting Atrial Fibrillation | 8,9 | ||||
Microlife WatchBP O3 (3MZ0) | Pass | At rest | 2 | ||
Microlife WatchBP O3 (3MZ1) | Pass | At rest | 3 | ||
Wrist devices | |||||
Device | AAMI | BHS | ESH | Circumstance | Reference |
Microlife BP W100 | Pass | A/A | Pass | Supine position | 20 |
Microlife BP W200-1 | Pass | MAM averaging and supine position | 21 |
* Indicates that the same validation applies to the device because of equivalence
Sources: | ||||||
BHS - British Hypertension Society | ||||||
dableducational Trust |
BHS - British Hypertension Society | ||||||
BHS A/A | ||||||
![]() | Microlife Blood Pressure Monitors are successfully validated according to the protocol of the BHS (British Hypertension Society). Microlife's upper automatic arm devices are validated with the highest possible grade of A/A. | |||||
BHS A/B | ||||||
![]() | ||||||
European Society of Hypertension | ||||||
ESH Protocol | ||||||
![]() | Microlife Blood Pressure Monitors are successfully validated according to the International Protocol of the ESH (European Society of Hypertension). | |||||
Gütesiegel | ||||||
![]() | It is the aim of the German Hypertension Society to improve measurement accuracy, by testing and awarding Blood Pressure Monitoring devices that fulfill its own test criteria following the strict protocol of the German Hypertension Society. |
1. | de Greeff A, Nathan H, Stafford N, Liu B, Shennan AH. Development of an accurate oscillometric blood pressure device for low resource settings. Blood Press Monit 2008;13:342-8. |
2. | Stergiou GS, Tzamouranis D, Nasothimiou EG, Karpettas N, Protogerou A. Are there really differences between home and daytime ambulatory blood pressure? Comparison using a novel dual-mode ambulatory and home monitor. J Hum Hypertens 2010;24:207-12. |
3. | Ragazzo F, Saladini F, Palatini P. Validation of the Microlife WatchBP O3 device for clinic, home, and ambulatory blood pressure measurement, according to the International Protocol. Blood Press Monit 2010;15:59-62. |
4. | Stergiou GS, Tzamouranis D, Protogerou A, Nasothimiou E, Kapralos C. Validation of the Microlife Watch BP Office professional device for office blood pressure measurement according to the International protocol. Blood Press Monit 2008;13:299-303. |
5. | Saladini F, Benetti E, Masiero S, Palatini P. Accuracy of Microlife WatchBP Office ABI monitor assessed according to the 2002 European Society of Hypertension protocol and the British Hypertension Society protocol. Blood Press Monit 2011;16:258-61. |
6. | Masiero S, Saladini F, Benetti E, Palatini P. Accuracy of the Microlife large-extra large-sized cuff (32-52 cm) coupled to an automatic oscillometric device. Blood Press Monit 2011;16:99-102. |
7. | Kollias A, Xilomenos A, Protogerou A, Dimakakos E, Stergiou GS. Automated determination of the ankle-brachial index using an oscillometric blood pressure monitor: validation vs. Doppler measurement and cardiovascular risk factor profile. Hypertens Res 2011;34:825-30. |
8. | Wiesel J, Fitzig L, Herschman Y, Messineo FC. Detection of atrial fibrillation using a modified microlife blood pressure monitor. Am J Hypertens 2009;22:848-52. |
9. | Stergiou GS, Karpettas N, Protogerou A, Nasothimiou EG, Kyriakidis M. Diagnostic accuracy of a home blood pressure monitor to detect atrial fibrillation. J Hum Hypertens 2009;23:654-8. |
10. | Stergiou GS, Giovas PP, Neofytou MS, Adamopoulos DN. Validation of the Microlife BPA100 Plus device for self-home blood pressure measurement according to the International Protocol. Blood Press Monit 2006;11:157-60. |
11. | Topouchian JA, El Assaad MA, Orobinskaia LV, El Feghali RN, Asmar RG. Validation of two devices for self-measurement of brachial blood pressure according to the International Protocol of the European Society of Hypertension: the SEINEX SE-9400 and the Microlife BP 3AC1-1. Blood Press Monit 2005;10:325-31. |
12. | de Greeff A, Reggiori F, Anthony J, Shennan A. The Microlife 3AC1: An accurate blood pressure measurement device in pregnancy and pre-eclampsia. J Hypertens 2006;24. |
13. | Thompson AM, Eguchi K, Reznik ME, Shah SS, Pickering TG. Validation of an oscillometric home blood pressure monitor in an end-stage renal disease population and the effect of arterial stiffness on its accuracy. Blood Press Monit 2007;12:227-32. |
14. | Cuckson AC, Reinders A, Shabeeh H, Shennan AH. Validation of the Microlife BP 3BTO-A oscillometric blood pressure monitoring device according to a modified British Hypertension Society protocol. Blood Press Monit 2002;7:319-24. |
15. | Reinders A, Cuckson AC, Lee JT, Shennan AH. An accurate automated blood pressure device for use in pregnancy and pre-eclampsia: the Microlife 3BTO-A. BJOG 2005;112:915-20. |
16. | Bonso E, Dorigatti F, Palatini P. Accuracy of the BP A100 blood pressure measuring device coupled with a single cuff with standard-size bladder over a wide range of arm circumferences. Blood Press Monit 2009;14:216-9. |
17. | Belghazi J, El Feghali RN, Moussalem T, Rejdych M, Asmar RG. Validation of four automatic devices for self-measurement of blood pressure according to the International Protocol of the European Society of Hypertension. Vasc Health Risk Manag 2007;3:389-400. |
18. | Stergiou GS, Giovas PP, Gkinos CP, Patouras JD. Validation of the Microlife WatchBP Home device for self home blood pressure measurement according to the International Protocol. Blood Press Monit 2007;12:185-8. |
19. | Chung Y, de Greeff A, Shennan A. Validation and compliance of a home monitoring device in pregnancy: microlife WatchBP home. Hypertens Pregnancy 2009;28:348-59. |
20. | Palatini P, Dorigatti F, Bonso E, Ragazzo F. Validation of Microlife BP W100 wrist device assessed according to the European Society of Hypertension and the British Hypertension Society protocols. Blood Press Monit 2009;14:41-4. |
21. | Palatini P, Dorigatti F, Bonso E, Ragazzo F. Validation of the Microlife BP W200-1 wrist device for blood pressure measurement. Blood Press Monit 2008;13:295-8. |